NILO AI LIMITED

Company number 13326771 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

NILO AI LIMITED - Analysis Report

Company Number: 13326771

Analysis Date: 2025-07-20 13:32 UTC

Financial Health Assessment for NILO AI LIMITED


1. Financial Health Score: D

Explanation:
NILO AI LIMITED demonstrates significant financial distress symptoms. Persistent and large negative net current assets, negative shareholders' funds, and declining total assets less current liabilities over four years reflect chronic liquidity and solvency problems. This grade indicates a fragile financial state requiring urgent remedial measures to restore health.


2. Key Vital Signs

Metric 2024 (£) Trend Interpretation
Fixed Assets 13,505 ↓ from 20,898 Shrinking investment in long-term assets, possible asset sales or depreciation.
Current Assets 1,196 ↓ from 1,483 Very low short-term resources to meet immediate obligations.
Current Liabilities 43,402 ↓ slightly from 44,794 Very high short-term debts compared to assets, indicating liquidity strain.
Net Current Assets -42,206 Slight improvement but still deeply negative Severe working capital deficiency; company likely struggles to pay short-term debts.
Total Assets less Current Liabilities -28,701 Worsened from -22,413 Overall net asset position is negative and deteriorating, indicating insolvency risks.
Shareholders' Funds -28,701 Deteriorated Negative equity, meaning debts exceed assets; shareholders’ capital is eroded.
Share Capital 100 Constant Nominal share capital; no significant equity buffer.
Number of Employees 2 Stable Small workforce consistent with micro entity classification.

3. Diagnosis: Financial Symptoms and Underlying Health

  • Liquidity Crisis ("Weak Pulse"): The company exhibits a "weak pulse" in liquidity, with current liabilities vastly outstripping current assets, creating a liquidity gap of over £42,000. This signals an inability to meet short-term obligations without external support or asset liquidation.

  • Capital Deficiency ("Anemia"): With shareholders' funds deeply negative and worsening year over year, the company is suffering from "anemia"—a lack of capital to sustain operations and absorb losses. This condition is precarious and may threaten ongoing viability.

  • Asset Shrinkage ("Muscle Wasting"): The decline in fixed assets suggests either asset disposals or accelerated depreciation, indicative of attempts to generate cash or reflecting underinvestment. This "muscle wasting" weakens the company's productive capacity.

  • No Audit Requirement: The company qualifies for audit exemption due to its micro status, but this could mean less rigorous financial scrutiny, which increases risk of undetected issues.

  • Stable Leadership: Directors and significant controllers remain consistent since incorporation, which is positive for governance, but financial distress may limit strategic flexibility.

  • Industry Context ("Freight Transport by Road"): The sector can be capital intensive with cash flow volatility. The current financial distress suggests the company is struggling to maintain operational stability in this demanding environment.


4. Recommendations: Treatment Plan for Financial Wellness

  1. Cash Flow Management ("Stabilize the Heartbeat")
    Implement strict cash flow monitoring and forecasting. Prioritize payments to critical creditors to maintain supply chain and service continuity. Explore short-term financing options such as overdrafts or invoice factoring to alleviate immediate pressure.

  2. Capital Injection ("Blood Transfusion")
    Consider equity financing or director loans to restore positive net assets. Negotiate with existing shareholders or new investors to inject funds, which will improve solvency and financial flexibility.

  3. Cost Rationalization ("Reduce Metabolic Demand")
    Review and reduce operating expenses aggressively, including potential renegotiation of supplier contracts and overheads. With only two employees, labor costs may already be minimal but ensure all expenditures are scrutinized.

  4. Asset Review ("Check Vital Organs")
    Evaluate fixed assets for potential sale or better utilization. Avoid further asset erosion that may weaken operational capacity unnecessarily.

  5. Strategic Review ("Diagnose Underlying Disease")
    Assess business model viability in the freight transport sector. Consider diversification, strategic partnerships, or rebranding (noting the recent name change) to improve market positioning and revenue generation.

  6. Professional Advice ("Consult Specialists")
    Engage financial advisors or turnaround specialists to assist with restructuring plans. Early intervention can prevent insolvency.

  7. Compliance Vigilance ("Maintain Health Records")
    Ensure timely filing of accounts and confirmation statements to avoid penalties and maintain credibility with stakeholders.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.